Saudi Pharmaceutical Industries and Medical Appliances Corp. (2070) is listed on Tadawul of the Saudi Exchange (Tadawul) under sector Pharma, Biotech & Life Science. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2025, Saudi Pharmaceutical Industries and Medical Appliances Corp. reported revenue of SAR 1.71B, net profit of SAR 197M, and earnings per share of SAR 1.54. Total assets stood at SAR 4.37B with total equity of SAR 1.60B and total liabilities of SAR 2.61B.

Operating cash flow for 2025 was SAR 273M, representing a cash conversion ratio of 1.39 relative to net profit. Free cash flow was SAR 188M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR 1.39 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 1.39.

Revenue growth from 2024 to 2025: +1.5%. Net profit growth over the same period: +518.1%. 3-year revenue CAGR: 25.7%.

Key financial ratios for 2025: Return on Equity 12.3%, Return on Assets 4.5%, Net Margin 11.5%, Debt to Equity 1.63.

In 2024, Saudi Pharmaceutical Industries and Medical Appliances Corp. reported revenue of SAR 1.68B and net profit of SAR 32M, compared to SAR 1.71B and SAR 197M respectively in 2025.